Clinical Trials in Cardiology - E

Maintained by Dr. Olga Shindler. Last update on: February 20, 2001.

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

EAFT
European Atrial Fibrillation Trial
(a) Lancet 1993;342:1255-62
(b) N Engl J Med 1995;333:5-10

EAMI
Exercise training in Anterior Myocardial Infarction

EARS
European Atherosclerosis Research Study
Int J Epidemiol 1994;23:465-71

EAS
Edinburgh Artery Study

EASI
European Antiplatelet Stent Investigation

EAST
Emory Angioplasty versus Surgery Trial
(a) Am J Cardiol 1997;79:1453-9
(b) Circulation 1990;82(suppl 3):III-508
(c) N Engl J Med 1994;331:1044-1050
(d) Circulation 1995;92:2831-2840

EAST (8 year mortality data)
Emory Angioplasty versus Surgery Trial
J Am Coll Cardiol 2000;35:1116-1121

ECA
Epidemiologic Catchment Area study

ECASS
European Cooperative Acute Stroke Study
Jama 1995;274:1017-25
Jama 1995;274:1058-9

ECAT
European Concerted Action on Thrombosis and disabilities

ECAT AP
ECAT Angina Pectoris study

ECCE
Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction
Herz 1993;18:424-9

ECCIS
Epidemiologia e Clinica della Cardiopatia Ischemica Silente

ECCOMAC
European Concerted COMmunity ACtion programmes

EC/IC
ExtraCranial/IntraCranial arterial bypass study

ECLA
Estudios Cardiologicos LatinoAmerica
Circulation 1998;98:2227-2234

ECSG
European Cooperative Study Group for rt-PA in acute myocardial infarction

ECSG 1
European Cooperative Study Group for recombinant tissue-type plasminogen activator
Lancet 1985;i:842-7

ECSG 2
European Cooperative Study Group for recombinant tissue-type plasminogen activator
Lancet 1985;ii:965-9

ECSG 3
European Cooperative Study Group for recombinant tissue-type plasminogen activator
Am J Cardiol 1987;60:231-7

ECSG 4
European Cooperative Study Group for recombinant tissue-type plasminogen activator
Lancet 1988;i:197-203

ECSG 5
European Cooperative Study Group for recombinant tissue-type plasminogen activator
BMJ 1988;297:1374-9

ECSG 6
European Cooperative Study Group for recombinant tissue-type plasminogen activator
(a) Br Heart J 1992;67:122-8
(b) Am J Cardiol 1993;71524-8

ECSS
European Coronary Surgery Study

ECST
European Carotid Surgery Trial
Lancet 1991;337:1235-43

ECTIM
Etude Cas-Temoins sur I'Infarctus du Myocarde
Eur Heart J 1995;16:348-53

EDIC
Echocardiography Dobutamine International Cooperative study

EDIT
Early Defibrillator Implantation Trial

EDIT
Early Diabetes Intervention Trial

EECP
Enhanced External Counter Pulsation study

EFS
European Fraxiparin Study

EHVT
Edinburgh Heart Valve Trial

EIHDW
Evaluation of Ischemic Heart Disease in Women

EIS
European Infarction Study
Eur Heart J 1984;5:189-202

ELAT
Embolism in Left Atrial Thrombi study

ELCA
Excimer Laser Coronary Angioplasty registry

ELITE
Evaluation of Losartan In The Elderly
Lancet 1997;349:747-752

ELITE II
Evaluation of Losartan In The Elderly II
(a) J Card Fail 1999;5:146-154
(b) Lancet 2000;355:1582-1587

ELSA
European Lacidipine Study on Atherosclerosis
(a) J Cardiovasc Pharmacol 1995;25(suppl 3):S11-6
(b) Blood Press 1996;5(suppl 4):20-52

ELSA
European Longitudinal Study on Aging

ELSO
Extracorporeal Life Support Organization registry

ELVD
Exercise in Left Ventricular Dysfunction trial

EMERA
Estudio Multicentrico Estreptoquinasa Republica Argentina

EMERAS
Estudio Multicentrico Estreptoquinasa Republicas de Americas del Sur
lancet 1993;342:767-772

EMERALD
European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide
Circulation 1999;99:2486-2491

EMIAT
European Myocardial Infarction Amiodarone Trial
(a) Arch Mal Coeur 1991;84:67-9
(b) Am J Cardiol 1993;72:95F-8F
(c) Eur Heart J 1994;15:620-4
(d) Lancet 1997;349:667-674

EMIAT
European Myocardial Infarction Arrhythmia Trial

EMIP
European Myocardial Infarction Project
(a)Eur Heart J 1988;9(suppl):129
(b)Eur Heart J 1990;11(suppl F):43-7
(c)N Engl J Med 1993;329:383-389

EMIP-FR
European Myocardial Infarction Project - Free Radicals
Eur Heart J. 1993 Nov;14 Suppl G:48-51

EMIT
European Mivazerol Trial
Anesthesiology 1999;99:951-961

EMPAR
Enoxaparin MaxEPA Prevention of Angioplasty Restenosis
Circulation 1996;94:1553-1560

EMS
European Multicenter Study

ENASA
ENoxaparin and/or ASpirin in unstable Angina

ENDPT
END PoinT of flow velocity after angioplasty

ENDPT
EvaluatioN of Doppler Parameters during PTCA

ENOXART
ENOXaparin in ARTerial surgery

ENRICHD
ENhancing Recovery in Coronary Heart Disease
Am Heart J 2000;139:1-9

ENTICES
ENoxaparin and TIClopidine after Elective Stenting
J Am Coll Cardiol 1996;27:334A

ENTIM
Etudes des Nouveaux Thrombolytiques dans Infarctus du Myocarde
(a) Circulation 1990;82(suppl 3):III-726
(b) Circulation 1990;82(suppl 3):III-665
(c) Circulation 1991;84:1107-17

EOL
End-Of-Life study

EPAMSA
Estudio Piloto Argentino de Muerte Subita y Amiodarona
Am Heart J 1995;130:494-500

EPCOT
European Prospective Cohort On Thrombophilia

EPESE
Established Populations for Epidemiologic Studies of the Elderly

EPIC
Echocardiography Persantine International Cooperative study
JACC Vol. 27, No. 8, July 1996:45-51

EPIC
Echo Persantine Italian Cooperative study

EPIC
European Prevalence of Infection in Intensive Care Study

EPIC
Evaluation of Ilb/Illa Platelet receptor antagonist 7E3 in Preventing Ischemic Complications
(a) Lancet 1994;343:881-886 (b) N Engl J Med 1994;330:956-961
(c) Am J Cardiol 1995;75:559-62
(d) Eur Heart J 1995;16(suppl L):43-9
(e) Am J Cardiol 1996;77:1045-51
(f) J Am Coll Cardiol 1996;28:849-55
(g) JAMA. 1997 Aug 13;278(6):479-84
(h) Am J Cardiol 1997;80:985-988

EPIC (Substudy)
Evaluation of c7E3 for the Prevention of Ischemic Complications
J Am Coll Cardiol 1998;32:311-319

EPILOG
Evaluation of PTCA to Improve Long-term Outcome by c7E3 GPIIb/IIIa receptor blockade
N Engl J Med 1997;336:1689-1696

EPILOG Substudy
Evaluation in PTCA to Improve Long-term Outcome with Abciximab GP IIb/IIIa blockade
Circulation 1998;97:857-864

EPILOG - One year Outcome
Evaluation in PTCA to Improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade
Circulation 1999;99:1951-1958

EPISODE
Evaluation Peripheral Intravascular Sonography On Dotter Effect

EPISTENT
Evaluation of Platelet IIb/IIIa Inhibition for Stenting
Lancet 1998;352:87-92

EPISTENT (6 month outcome)
Evaluation of Platelet IIb/IIIa Inhibition for Stenting
N Engl J Med 1999;341:319-327

EPISTENT (Diabetic Substudy)
Evaluation of Platelet IIb/IIIa Inhibition for Stenting
Circulation 1999;100:2477-2484

EPISTENT (Substudy)
Evaluation of Platelet IIb/IIIa Inhibition for Stenting
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting.
Jama 1999;281:806-810

EPOCH
ErythroPOietin made in Chinese Hamster ovary study

EPOZ
Epidemiological Preventive Organization Zoetermeer study

EPPAC
Etude de la PermeabiIities des Pontages AortoCoronaires a 6 mois

EPPI
Etude de Prescription Post Infarctus

EPRCSS
European Prospective Randomised Coronary Surgery Study

EPREDA
Essai PReEclampsia Dipyridamole Aspirine

EPRS
European Prospective Randomised Study

EPSIM
Enquete de Prevention Secondaire de I'Infarctus du Myocarde
N Engl J Med 1982;307:701-8

EQOL
Economics and Quality of Life substudy of GUSTO

EQUIPP
Evaluation of QUinapril In Primary Practice

ERA
Echo Record Access study

ERA
Enoxaparin Restenosis after Angioplasty
Circulation 1994;90:908-914

ERA
Estrogen Replacement and Atherosclerosis trial

ERACI
Estudio Randomizado Argentino de Angioplastia vs CIrugia
J Am Coll Cardiol 1993;22:1060-1067

ERASE Chest-Pain
Emergency Room Assessment of Sestamibi for Evaluating Chest Pain

ERASER
Evaluation of Reo Pro And Stenting to Eliminate Restenosis
Circulation 1999;100:799-806

ERAYTIC
Etude dans la maladie de RAYnaud avec la TIClopidine

ERBAC
Excimer laser, Rotablator and Balloon Angioplasty Comparison
Circulation 1997;96:91-98

ERICA
European Risk and Incidence, a Coordinated Analysis
(a) Eur Heart J 1988;9(suppl 1):1-36
(b) Eur Heart J 1991;12:291-7
(b) Eur Heart J 1992;12:291-7

ERNST
European Resuscitation Nimodipine Study

ESBY
Electrical Stimulation Bypass Surgery study
Circulation 1998 Mar 31;97(12):1157-63

ESCALAT
Efegartran sulfate as an adjunct to Streptokinase vs heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction
A Heart J 1999;138:696-704

ESCALATE
Efegartran and Streptokinase to Canalize Arteries Like Accelerated TissuE plasminogen activator

ESCOBAR
Emergency Stenting compared to Conventional Balloon Angioplasty Randomized trial

ESMIR
Echocardiographic Selection of patients for Mitral Regurgitation study

ESPIRAL
Effects of antihypertensive treatment on progression of renal insufficiency
Nefrologia 1995;15:464-75

ESPRIM
European Study Prevention Research of infarct with Molsidomine
Lancet 1994;344:91-97

ESPRIT
Efficacy Safety Proective Randomized Ibopamine Trial

ESPRIT
Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy

ESPRIT
European Study of the Prevention of Reocclusion after Initial Thrombolysis
Eur Heart J 1996;17:1522-31

ESPRIT
European Study Programme for the Relevance of Immunology in liver Transplantation

ESPS
European Stroke Prevention Study

ESSENCE
Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events
(a) N Engl J Med 1997;337:447-452
(b) J Thromb Thrombolysis 1997;4:271-4
(c) Circulation 1998;97:1702-1707

ESSENCE (Substudy)
Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events

EST
Early Stroke Trial

ESTIC
Estudio on Survival and Treatment in Insuficiencia Cardiaca in Spain (Estudio Supervivencia en el Tratamiento de la insufficiencia Cardiaca)
J Heart Failure 1993;1(abstract suppl):abstract 187

ESVEM
Electrophysiologic Study Versus Electrocardiographic Monitoring
(a) Circulation 1989;79:1354-60
(b) Circulation 1993;87:323-329
(c) N Engl J Med 1993;329:445-51
(d) N Engl J Med 1993;329:452-8
(e) N Trends Arrhythmias 1994;9:1183-5
(f) Circulation 1995;91:1070-1076
(g) Circulation 1995;91:1988-1995
(h) Prog Cardiovasc Dis 1996;38:347-58
(i) Prog Cardiovasc Dis 1996;38:359-70

ETAMIN
Effects of Ticlopidine on Atherosclerosis Membri INferii

ETCI
Etude Tanakan Claudication lntermittente

ETDRS
Early Treatment Diabetic Retinopathy Study

EURAMIC
EURopean community multicenter study on Antioxidants, Myocardial Infarction, and breast Cancer
Lancet 1993;342:1379-84

EURID
EUropean Registry for Implantable cardioverter Defibrillators

EUROCARE
EUROpean CArvedilol REstenosis trial

EUROSCOP
EUROpean Registry Society study on Chronic Obstructive Pulmonary disease

EVA
Epidemiological study on Vascular and cognitive Aging
Atherosclerosis 1996;120:47-55

EVA
European Vascular Agency study

EVADE
Experience with left Ventricular Assist Device with Exercise trial

EVADIAC
EVAluation dans le Diabete du traitement par Implants ACtifs

EVAS-IM
Etude Vaudois APSAC vs Streptokinase dans Infarctus du Myocarde

EVT
EndoVascular Technologies,Inc. Trial for abdominal aortic aneurysm repair

EWGCP
European Working Group on Cardiac Pacing

EWPHE
European Working Party on Hypertension in the Elderly
Am J Med 1991;90(suppl 3A):3A-1S-64S and addenda

EWR
European Wallstent Registry

EXACTO
EXcimer laser Angioplasty in Coronary Total Occlusions

EXCEL
EXpanded Clinical Evaluation of Lovastatin
(a) Am J Cardiol 1990;66:44B-55B
(b) Arch Intern Med 1991;151:43-9
(c) Am J Med 1991;91(suppl 1B):1B-18S-24S
(d) Am J Med 1991;91(suppl 1B):25S-30S
(e) Hypertension 1992;19:242-8
(f) Circulation 1992;85:1293-303
(g) Ann Intern Med 1993;118:850-5
(h) Am J Cardiol 1994;74:667-73

EXCITE
Evaluation of oral Xemilofiban In controlling Thrombotic Events
N Engl J Med 2000;342:1316-1324

Alphabetic list:
A / B / C / D / E / F / G / H / I / J / K / L / M /
N / O / P / Q / R / S / T / U / V / W / X / Y / Z /

e-mail:shindler@umdnj.edu
Copyright © 1995-2001 Dr. Olga Shindler.